Showing results (61-70 of 300) with videos related to
Sort By:
Pageof 30
Transplantation Proceedings|May 4, 2005
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximabB K Krämer, H-H Neumayer, R Stahl, et al.American Journal of Nephrology|January 1, 1987
Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized studyK Wagner, S Albrecht, H H NeumayerDeutsche Medizinische Wochenschrift (1946)|September 5, 1986
[Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study]K Wagner, S Albrecht, H H NeumayerKidney International. Supplement|May 1, 1992
Protective effects of calcium antagonists in human renal transplantationH H Neumayer, U Kunzendorf, M SchreiberClinical Nephrology|December 1, 1994
Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejectionS John, H H Neumayer, M WeberAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantationL Liefeldt, S Brakemeier, P Glander, et al.Renal Failure|January 1, 1993
Calcium antagonists and renal protectionH H Neumayer, J Gellert, F C LuftAdvances in Nutrition (Bethesda, Md.)|May 17, 2015
The science of fatty acids and inflammationKevin L FritscheProstaglandins, Leukotrienes, and Essential Fatty Acids|November 8, 2008
Too much linoleic acid promotes inflammation-doesn't it?Kevin L FritschePageof 30